Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1998-12-18
2000-01-25
Stucker, Jeffrey
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
4241841, 4241931, 42419611, 4242081, 4242771, 4242781, 4242801, 424450, 514 2, 514 8, 530350, 530806, 530826, 530330, 530331, A61K 3921
Patent
active
060175370
ABSTRACT:
The present invention relates to immunological adjuvants comprised of the N-formyl methionyl peptide fMLP. FMLP, when used as an adjuvant in accordance with the present invention, provides for an immune response to suboptimal doses of recombinant antigens.
REFERENCES:
Kashkin et al. "Immunoregulating Activity of a Chemotaxic Peptide Conjugated with a Liposomal Antigen", Immunologiya, No. 6,(1987), pp. 37-40. English translation provided by applicant's attorney.
Biotech Research strong possitve control serum Western blot strip, mid-80's .
Alexander Jeannine
Cox William I.
Connaught Laboratories Inc.
Howe Timothy R.
Smith G. Kenneth
Stucker Jeffrey
LandOfFree
Formyl methionyl peptide vaccine adjuvant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Formyl methionyl peptide vaccine adjuvant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formyl methionyl peptide vaccine adjuvant will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2313961